Novartis AG (FRA:NOTA)

bluebird bio Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	196,235	189,022	187,424	181,945	173,228	175,801
Market Cap Growth	-1.01%	0.85%	3.01%	5.03%	-1.46%	-8.19%
Enterprise Value	218,466	205,618	199,660	191,485	196,976	199,153
Last Close Price	95.20	89.45	83.14	76.85	69.15	66.13
PE Ratio	16.88	16.39	13.95	27.96	8.20	26.64
PS Ratio	4.18	3.78	4.44	4.47	4.48	4.31
PB Ratio	5.48	4.43	4.43	3.27	2.91	3.80
P/TBV Ratio	-	-	-	69.00	21.01	-
P/FCF Ratio	11.93	12.04	15.46	14.60	14.07	17.38
P/OCF Ratio	11.09	11.11	14.33	13.66	13.07	15.75
EV/Sales Ratio	4.63	4.12	4.73	4.71	5.09	4.88
EV/EBITDA Ratio	10.72	10.30	12.60	14.68	14.33	16.32
EV/EBIT Ratio	13.32	13.04	17.46	22.21	20.43	24.00
EV/FCF Ratio	13.28	13.10	16.47	15.36	16.00	19.69
Debt / Equity Ratio	0.78	0.71	0.57	0.47	0.46	0.67
Debt / EBITDA Ratio	1.37	1.50	1.49	1.97	1.95	2.49
Debt / FCF Ratio	1.69	1.93	1.97	2.10	2.22	3.08
Asset Turnover	0.55	0.51	0.43	0.35	0.34	0.41
Inventory Turnover	2.17	2.20	1.84	1.67	1.65	2.31
Quick Ratio	0.50	0.79	0.88	1.00	1.25	0.65
Current Ratio	0.82	1.03	1.16	1.29	1.51	0.90
Return on Equity (ROE)	32.49%	26.27%	16.15%	9.51%	36.80%	14.38%
Return on Assets (ROA)	11.88%	10.09%	7.27%	4.62%	5.28%	5.16%
Return on Capital (ROIC)	16.47%	13.72%	9.84%	6.18%	7.08%	7.07%
Return on Capital Employed (ROCE)	26.40%	22.20%	17.20%	10.40%	10.80%	10.70%
Earnings Yield	5.92%	6.10%	7.17%	3.58%	12.19%	3.75%
FCF Yield	8.39%	8.30%	6.47%	6.85%	7.11%	5.75%
Dividend Yield	3.04%	4.17%	4.26%	4.21%	4.32%	4.19%
Payout Ratio	57.26%	63.85%	48.85%	107.92%	30.67%	86.56%
Buyback Yield / Dilution	3.37%	2.73%	4.78%	2.79%	1.57%	0.99%
Total Shareholder Return	6.40%	6.89%	9.04%	7.00%	5.89%	5.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.